PEG-TGF peptantagonist (Auxagen)

N/A

Report date: 2025/01/26 17:51:00

Base Information

Drug NamePEG-TGF peptantagonist (Auxagen)
Drug Alias NamePEG-TGF peptide antagonist (Auxagen)PEG-TGF peptantagonist (Auxagen)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTransforming growth factor beta receptors antagonists
TargetsTransforming growth factor beta receptors
Therapy Area/IndicationsPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAuxagen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAuxagen Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A